Rocket Lab Targets Missile Defense and Golden Dome as Its Next Growth Market

Rocket Lab announced a partnership with RTX to work on space-based interceptor missiles under Golden Dome's $3.2 billion umbrella contract. The deal could materially expand Rocket Lab's addressable defense revenue, with the program potentially worth up to 4.7 times its $680 million trailing-12-month sales if bidding succeeds. The company also benefits from its existing PWSA prime contractor role and its Electron and future Neutron launch platforms, which strengthen its positioning in missile-defense space infrastructure.

Analysis

This is less about one subcontract and more about Rocket Lab moving from “adjacent space pure-play” to a credible defense execution partner. The second-order winner is RTX: it gains a lower-cost, more vertically integrated space launch and satellite-adjacent capability without having to build the full stack itself, which should improve bid competitiveness versus the legacy primes that are optimized for larger, slower programs. For Rocket Lab, the strategic value is that Golden Dome-style work could turn its launch cadence into a recurring national-security distribution channel, which is far more valuable than one-off launch revenue because it increases utilization and de-risks the Neutron commercialization story.

The market is likely underestimating schedule risk. Space-based interceptor programs tend to move from press-release enthusiasm to long qualification cycles, and the timing mismatch matters: near-term revenue will be lumpy, while the equity is already pricing a cleaner path to defense margin expansion. Any slip in Neutron, launch reliability, or subsystem qualification would quickly impair the bull case because this opportunity only compounds if Rocket Lab can demonstrate it is not just a launch provider but an integrated mission enabler.

The broader competitive read-through is negative for the primes that lack a nimble space-launch partner and positive for vertical-space suppliers with proven flight cadence. If RTX wins meaningful share, it may force Lockheed and Northrop to either accelerate M&A/partnerships or accept margin dilution to keep up. The contrarian point is that this could be a channel-share story, not a TAM-expansion story: the same defense dollars may simply migrate toward the best-integrated stack, so relative winners matter more than the absolute program headline.

The cleanest trade is to own RTX over the prime basket if you want Golden Dome exposure with better partner optionality, while treating RKLB as a high-beta call option on execution rather than a core defense name. The asymmetry is attractive over 6-12 months if additional subcontracts follow, but the downside is steep if the program remains politically important yet operationally slow, because enthusiasm can outrun booked revenue for several quarters.

Key Decisions for Investors

• Long RTX vs short a basket of legacy primes (LMT/NOC/GD) for 3-6 months: RTX has the best combination of program access and partner leverage; use a market-neutral pair to isolate share gain rather than sector beta.
• For higher beta, take a small RKLB long position only on pullbacks after launch-related weakness, sized as a 1-2% portfolio call option; thesis is 6-12 month multiple re-rating if follow-on defense work validates the platform.
• Buy RTX Jan-2027 calls on dips if implied vol compresses after the initial announcement bounce; the setup favors delayed contract visibility and multiple expansion over the next 2-4 quarters.
• Avoid chasing RKLB after headline spikes: the risk/reward worsens if investors price in revenue too early, and any Neutron or qualification delay can cut the stock sharply before actual defense cash flow arrives.